Publication | Closed Access

18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma

Positron Emission TomographyOncologic ImagingMedical ImagingRadiation TherapyMedicineSurvival PrognosisHead And Neck CancerRadiotherapy OutcomeNeck OncologyOncologyRadiation OncologyNuclear MedicineCancer ResearchRadiologyHealth Sciences